Cargando…

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartziokas, Konstantinos, Papathanasiou, Evgenia, Papaioannou, Andriana I., Papanikolaou, Ilias, Antonakis, Emmanouil, Makou, Ioanna, Hillas, Georgios, Karampitsakos, Theodoros, Papaioannou, Ourania, Dimakou, Katerina, Apollonatou, Vasiliki, Verykokou, Galateia, Papiris, Spyros, Bakakos, Petros, Loukides, Stelios, Kostikas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145416/
https://www.ncbi.nlm.nih.gov/pubmed/37109072
http://dx.doi.org/10.3390/jpm13040686
_version_ 1785034328184455168
author Bartziokas, Konstantinos
Papathanasiou, Evgenia
Papaioannou, Andriana I.
Papanikolaou, Ilias
Antonakis, Emmanouil
Makou, Ioanna
Hillas, Georgios
Karampitsakos, Theodoros
Papaioannou, Ourania
Dimakou, Katerina
Apollonatou, Vasiliki
Verykokou, Galateia
Papiris, Spyros
Bakakos, Petros
Loukides, Stelios
Kostikas, Konstantinos
author_facet Bartziokas, Konstantinos
Papathanasiou, Evgenia
Papaioannou, Andriana I.
Papanikolaou, Ilias
Antonakis, Emmanouil
Makou, Ioanna
Hillas, Georgios
Karampitsakos, Theodoros
Papaioannou, Ourania
Dimakou, Katerina
Apollonatou, Vasiliki
Verykokou, Galateia
Papiris, Spyros
Bakakos, Petros
Loukides, Stelios
Kostikas, Konstantinos
author_sort Bartziokas, Konstantinos
collection PubMed
description Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. Objectives: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. Methods: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/μL, was evaluated. Results Subjects with blood eosinophil number < 150 k/μL had a more severe disease on admission compared to subjects with ≥150 k/μL, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO(2)/FiO(2) levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = −0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO(2)/FiO(2) (p < 0.001, r = −0.248), and with duration of hospital stay (p < 0.001, r = −0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/μL was an independent predictor of the use of NIV during hospital stay. Conclusion: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes.
format Online
Article
Text
id pubmed-10145416
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101454162023-04-29 Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations Bartziokas, Konstantinos Papathanasiou, Evgenia Papaioannou, Andriana I. Papanikolaou, Ilias Antonakis, Emmanouil Makou, Ioanna Hillas, Georgios Karampitsakos, Theodoros Papaioannou, Ourania Dimakou, Katerina Apollonatou, Vasiliki Verykokou, Galateia Papiris, Spyros Bakakos, Petros Loukides, Stelios Kostikas, Konstantinos J Pers Med Brief Report Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. Objectives: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. Methods: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/μL, was evaluated. Results Subjects with blood eosinophil number < 150 k/μL had a more severe disease on admission compared to subjects with ≥150 k/μL, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO(2)/FiO(2) levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = −0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO(2)/FiO(2) (p < 0.001, r = −0.248), and with duration of hospital stay (p < 0.001, r = −0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/μL was an independent predictor of the use of NIV during hospital stay. Conclusion: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes. MDPI 2023-04-19 /pmc/articles/PMC10145416/ /pubmed/37109072 http://dx.doi.org/10.3390/jpm13040686 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Bartziokas, Konstantinos
Papathanasiou, Evgenia
Papaioannou, Andriana I.
Papanikolaou, Ilias
Antonakis, Emmanouil
Makou, Ioanna
Hillas, Georgios
Karampitsakos, Theodoros
Papaioannou, Ourania
Dimakou, Katerina
Apollonatou, Vasiliki
Verykokou, Galateia
Papiris, Spyros
Bakakos, Petros
Loukides, Stelios
Kostikas, Konstantinos
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
title Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
title_full Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
title_fullStr Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
title_full_unstemmed Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
title_short Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
title_sort eosinopenia as a prognostic biomarker for noninvasive ventilation use in copd exacerbations
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145416/
https://www.ncbi.nlm.nih.gov/pubmed/37109072
http://dx.doi.org/10.3390/jpm13040686
work_keys_str_mv AT bartziokaskonstantinos eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT papathanasiouevgenia eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT papaioannouandrianai eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT papanikolaouilias eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT antonakisemmanouil eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT makouioanna eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT hillasgeorgios eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT karampitsakostheodoros eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT papaioannouourania eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT dimakoukaterina eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT apollonatouvasiliki eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT verykokougalateia eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT papirisspyros eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT bakakospetros eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT loukidesstelios eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations
AT kostikaskonstantinos eosinopeniaasaprognosticbiomarkerfornoninvasiveventilationuseincopdexacerbations